Laurus Labs Declares Dividend As Q4 Revenue Hits ₹18.12 Billion

The announcement underscores Laurus Labs’ resilience in navigating global demand challenges while maintaining profitability.  

Quarterly Performance  

Revenue of ₹18.12 billion reflects consistent demand across active pharmaceutical ingredients (APIs), formulations, and contract research services. The company’s diversified portfolio has helped sustain growth despite pricing pressures in global markets.  

Dividend Declaration  

The board’s approval of a ₹1.2 per share dividend signals confidence in Laurus Labs’ financial strength and cash flow stability. The payout demonstrates the company’s focus on rewarding shareholders while maintaining investment in innovation and expansion.  

Strategic Outlook  

Laurus Labs continues to strengthen its presence in APIs and formulations, with a growing emphasis on biotechnology and contract development services. Analysts believe the company’s focus on innovation and global partnerships positions it well for long-term growth.  

Financial Highlights  

• Q4 consolidated revenue at ₹18.12 billion  
• Dividend of ₹1.2 per share declared  
• Strong demand across APIs and formulations  
• Focus on biotechnology and global partnerships  

Sources: Reuters, Economic Times, Business Standard